Nautilus Biotechnology NAUT
NASDAQ NAUT
$2.55 -0.08 (-3.04%)
At close: Oct 20, 2026 · 4:00 PM EDT

Nautilus Biotechnology (NAUT) EBIT Margin (2026)

Updated

Nautilus Biotechnology's EBIT Margin was -8296.32% in Q2 2026.

Analysis

Nautilus Biotechnology (NAUT) EBIT Margin (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn 13.44%
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn 33.60%
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn 18.08%
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn 25.18%
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn 21.65%
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 29.48%
10 Nautilus Biotechnology 323.56 Mn -91.17 Mn 175,000.00 -8,296.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,296.32%
API Access

Nautilus Biotechnology EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NAUT&period=max&api_key=YOUR_API_KEY